Strides Arcolab stronger than Orchid Chemicals: Seshadri Bharatan

Seshadri Bharatan, Investment Analyst, in a chat with ET Now, talks about pharma stocks.

In the pharma space, have you looked at an Orchid or Strides which have been abuzz? Do you like either of these two?

At this point of time, I am more inclined towards Strides Arcolab. We have seen that last week one of their generated drugs was approved by US FDA. So yes, there are lot of streams of income being built in as the generic market opens for some of these companies and Strides Arcolab among these two is showing more strength on the charts compared to Orchid Chemicals.
ADVERTISEMENT
READ MORE

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Strides Arcolab stronger than Orchid Chemicals: Seshadri Bharatan
Text Size:AAA
Success
This article has been saved

*

+